Odyssey Group International, Inc. (ODYY)
USD 0.01
(5.26%)
USD 0.01
(5.26%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 6.61 Million USD | 26.82% |
| 2022 | 5.21 Million USD | 54.34% |
| 2021 | 3.37 Million USD | 346.18% |
| 2020 | 757.06 Thousand USD | -40.59% |
| 2019 | 1.27 Million USD | 50.47% |
| 2018 | 846.83 Thousand USD | 46.23% |
| 2017 | 579.11 Thousand USD | 85.13% |
| 2016 | 312.82 Thousand USD | 91.15% |
| 2015 | 163.65 Thousand USD | -35.46% |
| 2014 | 253.58 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 5.37 Million USD | -21.24% |
| 2024 Q3 | 5.69 Million USD | 5.89% |
| 2024 Q1 | 6.83 Million USD | 3.31% |
| 2023 FY | 6.61 Million USD | 26.82% |
| 2023 Q4 | 6.61 Million USD | 5.68% |
| 2023 Q3 | 6.25 Million USD | 7.31% |
| 2023 Q1 | 6.25 Million USD | 19.91% |
| 2023 Q2 | 5.83 Million USD | -6.74% |
| 2022 Q3 | 4.69 Million USD | 4.16% |
| 2022 Q2 | 4.51 Million USD | 14.86% |
| 2022 Q1 | 3.92 Million USD | 16.27% |
| 2022 FY | 5.21 Million USD | 54.34% |
| 2022 Q4 | 5.21 Million USD | 10.95% |
| 2021 Q2 | 1.15 Million USD | 21.74% |
| 2021 Q3 | 2.4 Million USD | 107.9% |
| 2021 Q4 | 3.37 Million USD | 40.7% |
| 2021 Q1 | 948.56 Thousand USD | 25.29% |
| 2021 FY | 3.37 Million USD | 346.18% |
| 2020 FY | 757.06 Thousand USD | -40.59% |
| 2020 Q1 | 1.35 Million USD | 6.47% |
| 2020 Q4 | 757.06 Thousand USD | -54.16% |
| 2020 Q3 | 1.65 Million USD | 11.67% |
| 2020 Q2 | 1.47 Million USD | 9.0% |
| 2019 Q2 | 945.45 Thousand USD | 3.41% |
| 2019 Q4 | 1.27 Million USD | 26.75% |
| 2019 Q3 | 1 Million USD | 6.33% |
| 2019 FY | 1.27 Million USD | 50.47% |
| 2019 Q1 | 914.3 Thousand USD | 7.97% |
| 2018 FY | 846.83 Thousand USD | 46.23% |
| 2018 Q1 | 661.22 Thousand USD | 14.18% |
| 2018 Q2 | 713.25 Thousand USD | 7.87% |
| 2018 Q3 | 789.92 Thousand USD | 10.75% |
| 2018 Q4 | 846.83 Thousand USD | 7.2% |
| 2017 Q4 | 579.11 Thousand USD | 22.68% |
| 2017 FY | 579.11 Thousand USD | 85.13% |
| 2017 Q3 | 472.04 Thousand USD | 24.25% |
| 2017 Q2 | 379.92 Thousand USD | 7.48% |
| 2017 Q1 | 353.48 Thousand USD | 13.0% |
| 2016 FY | 312.82 Thousand USD | 91.15% |
| 2016 Q1 | 189.08 Thousand USD | 15.54% |
| 2016 Q4 | 312.82 Thousand USD | 6.94% |
| 2016 Q3 | 292.51 Thousand USD | 45.56% |
| 2016 Q2 | 200.95 Thousand USD | 6.27% |
| 2015 FY | 163.65 Thousand USD | -35.46% |
| 2015 Q4 | 163.65 Thousand USD | 16.46% |
| 2015 Q1 | 192.53 Thousand USD | 0.0% |
| 2015 Q3 | 140.51 Thousand USD | -19.59% |
| 2015 Q2 | 174.75 Thousand USD | -9.23% |
| 2014 FY | 253.58 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Avitar, Inc. | 11.59 Million USD | 42.971% |
| BioElectronics Corporation | 16.62 Million USD | 60.225% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | 634 Thousand USD | -942.858% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -875.733% |
| Polarean Imaging plc | 2.58 Million USD | -156.215% |
| AVITA Medical, Inc. | 19.86 Million USD | 66.717% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | -212.168% |
| Össur hf. | 688.8 Million USD | 99.04% |
| Zecotek Photonics Inc. | 5.86 Million USD | -12.663% |
| QHSLab, Inc. | 2.05 Million USD | -221.418% |
| Wellstar International, Inc. | 55.99 Million USD | 88.191% |
| Össur hf. | 688.8 Million USD | 99.04% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | 58.884% |
| Escalon Medical Corp. | 2.94 Million USD | -124.252% |
| Aurora Spine Corporation | 6.65 Million USD | 0.628% |
| BrainsWay Ltd. | 15.31 Million USD | 56.826% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 6.01 Million USD | -9.964% |
| Hamilton Thorne Ltd. | 45.84 Million USD | 85.577% |
| Vivos Inc. | 245 Thousand USD | -2598.618% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 99.734% |
| Kelyniam Global, Inc. | 1.01 Million USD | -552.729% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -2298.906% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | -169.887% |
| Nanomix Corporation | 14.81 Million USD | 55.371% |
| Theraclion SA | 13.01 Million EUR | 49.205% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 5.12 Million USD | -29.029% |
| Positron Corporation | 2.02 Million USD | -226.344% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | -82.585% |
| Lombard Medical, Inc. | 53.79 Million USD | 87.709% |
| ALR Technologies Inc. | 24.5 Million USD | 73.019% |
| Stratec SE | 271.97 Million USD | 97.569% |
| Vycor Medical, Inc. | 4.31 Million USD | -53.128% |
| Heart Tronics, Inc. | 1.09 Million USD | -503.927% |
| Nu-Med Plus, Inc. | 2.35 Million USD | -180.302% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | -20.728% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 89.92% |
| VMS Rehab Systems, Inc. | 201.36 USD | -3283432.976% |
| Guided Therapeutics, Inc. | 5.47 Million USD | -20.762% |
| Ingen Technologies, Inc. | 5.7 Million USD | -15.801% |
| United American Healthcare Corporation | 119 Thousand USD | -5456.069% |
| ECGI Holdings, Inc. | 11.94 Million USD | 44.627% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -399.381% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | -357.136% |
| Urologix, Inc. | 12.64 Million USD | 47.709% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | -22.529% |
| Nexeon MedSystems Inc. | 8.48 Million USD | 22.054% |
| SS Innovations International, Inc. | 11.18 Million USD | 40.867% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -1158.448% |
| Smith & Nephew plc | 4.76 Billion USD | 99.861% |
| NIOX Group Plc | 9.8 Million USD | 32.548% |
| Fuse Medical, Inc. | 15.11 Million USD | 56.243% |
| Broncus Holding Corporation | 10.43 Million USD | 36.622% |
| Brain Scientific Inc. | 7.42 Million USD | 10.97% |
| Pressure BioSciences, Inc. | 33.8 Million USD | 80.441% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -732.626% |